Bullfrog AI Holdings, Inc. (BFRG)Healthcare | Health Information Services | Gaithersburg, United States | NasdaqCM
0.99 USD
-0.09
(-7.935%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.99 0.00 (-0.003%) ⇩ (April 17, 2026, 7:53 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 1:03 a.m. EDT
Despite a one-day 122% surge driven by a new pharma contract, BFRG exhibits the classic pattern of a penny stock pump followed by a violent correction; the underlying fundamentals—severe negative cash flow, negative ROE, and massively inflated valuations—indicate that the 'drug discovery workflow' and contract wins are not enough to sustain long-term stability, making this a high-risk speculative trap rather than a genuine investment thesis. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.283277 |
| AutoETS | 0.283280 |
| MSTL | 0.285504 |
| AutoTheta | 0.290094 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 2.81 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.008 |
| Excess Kurtosis | 0.19 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.011 |
| Market Cap | 18,341,956 |
| Beta | -2.30 |
| Website | https://www.bullfrogai.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.40120482 |
| Address1 | 325 Ellington Boulevard |
| Address2 | Unit 317 |
| All Time High | 9.5 |
| All Time Low | 0.425 |
| Ask | 1.27 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 4,018,960 |
| Average Daily Volume3 Month | 11,566,739 |
| Average Volume | 11,566,739 |
| Average Volume10Days | 4,018,960 |
| Beta | -2.295 |
| Bid | 0.756 |
| Bid Size | 2 |
| Book Value | 0.187 |
| City | Gaithersburg |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.9943 |
| Current Ratio | 3.845 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.06 |
| Day Low | 0.99 |
| Display Name | Bullfrog AI |
| Earnings Timestamp End | 1,754,510,400 |
| Earnings Timestamp Start | 1,754,510,400 |
| Ebitda | -6,592,911 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.579 |
| Enterprise To Revenue | 89.213 |
| Enterprise Value | 10,408,496 |
| Eps Trailing Twelve Months | -0.63 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.72316 |
| Fifty Day Average Change | 0.27113998 |
| Fifty Day Average Change Percent | 0.37493774 |
| Fifty Two Week Change Percent | -40.120483 |
| Fifty Two Week High | 2.04 |
| Fifty Two Week High Change | -1.0457 |
| Fifty Two Week High Change Percent | -0.51259804 |
| Fifty Two Week Low | 0.425 |
| Fifty Two Week Low Change | 0.5693 |
| Fifty Two Week Low Change Percent | 1.3395294 |
| Fifty Two Week Range | 0.425 - 2.04 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,676,298,600,000 |
| Float Shares | 10,223,833 |
| Free Cashflow | -3,317,732 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.18764 |
| Gross Profits | 21,892 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.19705 |
| Held Percent Institutions | 0.03977 |
| Implied Shares Outstanding | 18,447,105 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Ipo Expected Date | 2,023-02-14 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland. |
| Long Name | Bullfrog AI Holdings, Inc. |
| Market | us_market |
| Market Cap | 18,341,956 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1782843252 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -6,498,068 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 18,341,956 |
| Open | 1.06 |
| Operating Cashflow | -5,522,265 |
| Operating Margins | -56.523838 |
| Payout Ratio | 0.0 |
| Phone | 240 658 6710 |
| Post Market Change | -0.0031000376 |
| Post Market Change Percent | -0.3117809 |
| Post Market Price | 0.9912 |
| Post Market Time | 1,776,470,031 |
| Previous Close | 1.08 |
| Price Hint | 4 |
| Price To Book | 5.317112 |
| Price To Sales Trailing12 Months | 157.21228 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.249 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0857 |
| Regular Market Change Percent | -7.93519 |
| Regular Market Day High | 1.06 |
| Regular Market Day Low | 0.99 |
| Regular Market Day Range | 0.99 - 1.06 |
| Regular Market Open | 1.06 |
| Regular Market Previous Close | 1.08 |
| Regular Market Price | 0.9943 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 690,146 |
| Return On Assets | -0.98601997 |
| Return On Equity | -1.83042 |
| Revenue Per Share | 0.011 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 18,447,105 |
| Shares Percent Shares Out | 0.4628 |
| Shares Short | 5,860,784 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 647,761 |
| Short Name | Bullfrog AI Holdings, Inc. |
| Short Percent Of Float | 0.5702 |
| Short Ratio | 0.21 |
| Source Interval | 15 |
| State | MD |
| Symbol | BFRG |
| Total Cash | 2,183,705 |
| Total Cash Per Share | 0.172 |
| Total Debt | 0 |
| Total Revenue | 116,670 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.63 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.068845 |
| Two Hundred Day Average Change | -0.074545026 |
| Two Hundred Day Average Change Percent | -0.06974353 |
| Type Disp | Equity |
| Volume | 690,146 |
| Website | https://www.bullfrogai.com |
| Zip | 20,878 |